Daniel F Hanley Selected Research

Daniel F Hanley Research Topics

Disease

39	Cerebral Hemorrhage 10/2022 - 01/2005
35	Hemorrhage 10/2022 - 11/2003
22	Stroke (Strokes) 10/2022 - 11/2002
16	Hematoma 10/2022 - 01/2005
9	Intracranial Hemorrhages (Intracranial Hemorrhage) 03/2021 - 09/2011
6	Edema (Dropsy) 01/2021 - 01/2008
5	Hypertension (High Blood Pressure) 01/2021 - 03/2010
3	Inflammation (Inflammations) 01/2021 - 01/2005
3	Hydrocephalus (Hydrocephaly) 01/2021 - 03/2010
3	Neoplasms (Cancer) 01/2020 - 12/2016
3	Peripheral Arterial Disease 03/2017 - 01/2016
3	Myocardial Infarction 03/2017 - 01/2016
3	Thrombosis (Thrombus) 05/2012 - 03/2004
3	Heart Arrest (Cardiac Arrest) 03/2008 - 11/2002
2	COVID-19 01/2022 - 01/2022
2	Infections 01/2022 - 01/2016
2	Bacterial Infections (Bacterial Infection) 08/2021 - 11/2016
2	Ischemic Stroke 01/2021 - 01/2016
2	Brain Injuries (Brain Injury) 01/2021 - 10/2007
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2021 - 04/2015
2	Diplopia (Double Vision) 03/2017 - 01/2016
2	Pneumonia (Pneumonitis) 01/2016 - 12/2002
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 04/2015 - 06/2002
1	Rupture 12/2022
1	Intracranial Aneurysm (Cerebral Aneurysm) 12/2022
1	Hyperglycemia 04/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Disease Progression 12/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2021
1	Diabetes Mellitus 10/2020
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Consciousness Disorders 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Traumatic Intracranial Hemorrhage 01/2020

Drug/Important Bio-Agent (IBA)

28	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 04/2009
7	Antihypertensive Agents (Antihypertensives)IBA 10/2022 - 01/2019
5	AnticoagulantsIBA 01/2021 - 03/2016
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 02/2008
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2017 - 02/2008
4	Clopidogrel (Plavix)FDA Link 03/2017 - 02/2008
3	Nicardipine (Dagan)FDA LinkGeneric 10/2022 - 01/2016
3	Thrombin FDA Link 01/2021 - 01/2016
3	Saline SolutionIBA 10/2020 - 03/2004
3	salicylhydroxamic acid (SHAM)IBA 01/2018 - 10/2007
3	vorapaxarIBA 03/2017 - 01/2016
2	Monoclonal AntibodiesIBA 12/2022 - 01/2022
2	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 10/2015
2	VaccinesIBA 01/2022 - 12/2021
2	Vitamin K FDA Link 01/2021 - 01/2020
2	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2021 - 01/2009
2	Warfarin (Coumadin)FDA LinkGeneric 10/2020 - 01/2020
2	HaptoglobinsIBA 10/2020 - 04/2015
2	Pharmaceutical PreparationsIBA 12/2019 - 01/2016
2	diazonaphthalenedisulfonic acid (NDS)IBA 12/2005 - 11/2002
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 03/2004 - 11/2003
1	Chloroquine (Aralen)FDA LinkGeneric 01/2022
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Neuroprotective AgentsIBA 01/2021
1	EnzymesIBA 01/2021
1	Immunologic Factors (Immunomodulators)IBA 01/2021
1	ImmunosorbentsIBA 01/2021
1	LigandsIBA 01/2021
1	LipidsIBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Dinoprostone (PGE2)FDA Link 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	CytokinesIBA 01/2021
1	Interleukin-8 (Interleukin 8)IBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	ChemokinesIBA 01/2021
1	Deferoxamine (Desferal)FDA LinkGeneric 11/2020
1	Hemostatics (Antihemorrhagics)IBA 10/2020
1	CreatinineIBA 10/2020
1	Hemoglobins (Hemoglobin)IBA 10/2020
1	P-2 (P 2)IBA 01/2020
1	apixabanIBA 01/2020
1	Dabigatran FDA Link 01/2020
1	RivaroxabanIBA 01/2020
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2020

Therapy/Procedure

19	Therapeutics 01/2022 - 11/2002
17	Minimally Invasive Surgical Procedures 01/2022 - 09/2011
7	Catheters 01/2019 - 09/2011
5	Ventriculostomy 03/2016 - 03/2004
3	Thrombolytic Therapy 01/2018 - 01/2003
3	Resuscitation 03/2008 - 11/2002
3	Critical Care (Surgical Intensive Care) 02/2003 - 06/2002
2	Craniotomy 01/2021 - 04/2014
2	Platelet Transfusion (Blood Platelet Transfusions) 10/2020 - 01/2020
2	Injections 01/2020 - 06/2014
2	Length of Stay 10/2016 - 01/2016
2	Artificial Respiration (Mechanical Ventilation) 03/2016 - 12/2002
2	Secondary Prevention 10/2015 - 02/2012
2	Intraventricular Injections 06/2014 - 03/2004
2	Transcranial Magnetic Stimulation 01/2009 - 02/2006
1	Complementary Therapies (Alternative Medicine) 01/2022
1	Thrombectomy 01/2021
1	Drug Therapy (Chemotherapy) 01/2020